Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
CYP3A4
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Function == CYP3A4 is a member of the [[cytochrome P450]] [[superfamily (molecular biology)|superfamily]] of [[enzyme]]s. The cytochrome P450 proteins are [[monooxygenase]]s that catalyze many reactions involved in [[drug metabolism]] and synthesis of [[steroid]]s (including [[cholesterol]]), and other [[lipid]]s.<ref name="refseq">{{NCBI RefSeq|title=CYP3A4 cytochrome P450 family 3 subfamily A member 4 [ Homo sapiens (human) ]|url=https://www.ncbi.nlm.nih.gov/gene/1576}}</ref> The CYP3A4 protein localizes to the [[endoplasmic reticulum]], and its expression is induced by [[glucocorticoid]]s and some pharmacological agents.<ref name="refseq"/> Cytochrome P450 enzymes metabolize approximately 60% of prescribed drugs, with CYP3A4 responsible for about half of this metabolism;<ref>{{cite journal | vauthors = Zanger UM, Schwab M | title = Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | journal = Pharmacology & Therapeutics | volume = 138 | issue = 1 | pages = 103β41 | date = April 2013 | pmid = 23333322 | doi = 10.1016/j.pharmthera.2012.12.007 | doi-access = free }}</ref> substrates include [[acetaminophen]] (paracetamol), [[codeine]], [[ciclosporin]] (cyclosporin), [[diazepam]], [[erythromycin]], and [[chloroquine]].<ref name="refseq"/> The enzyme also metabolizes some [[steroid]]s and [[carcinogen]]s.<ref name="entrez">{{EntrezGene|1576}}</ref> Most drugs undergo deactivation by CYP3A4, either directly or by facilitated [[excretion]] from the body. Also, many substances are [[bioactivation|bioactivated]] by CYP3A4 to form their active compounds, and many protoxins are [[toxicated]] into their toxic forms ''(see table below for examples)''. CYP3A4 also possesses [[epoxygenase]] activity in that it metabolizes [[arachidonic acid]] to [[epoxyeicosatrienoic acid]]s (EETs), i.e. (Β±)-8,9-, (Β±)-11,12-, and (Β±)-14,15-epoxyeicosatrienoic acids.<ref>{{cite journal | vauthors = Bishop-Bailey D, Thomson S, Askari A, Faulkner A, Wheeler-Jones C | title = Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism | journal = Annual Review of Nutrition | volume = 34 | pages = 261β79 | pmid = 24819323 | doi = 10.1146/annurev-nutr-071813-105747 | year = 2014 | url = https://rvc-repository.worktribe.com/preview/1659487/kura-et-al-2023-can-mass-drug-administration-of-moxidectin-accelerate-onchocerciasis-elimination-in-africa.pdf | access-date = 2 February 2024 | archive-date = 18 January 2024 | archive-url = https://web.archive.org/web/20240118040330/https://rvc-repository.worktribe.com/preview/1659487/kura-et-al-2023-can-mass-drug-administration-of-moxidectin-accelerate-onchocerciasis-elimination-in-africa.pdf | url-status = live }}</ref> EETs have a wide range of activities including the promotion of certain types of [[cancer]]s (see [[epoxyeicosatetraenoic acid#cancer|epoxyeicosatetraenoic acid]]). CYP3A4 promotes the growth of various types of human cancer cell lines in culture by producing (Β±)-14,15-epoxyeicosatrienoic acids, which stimulate these cells to grow.<ref>{{cite journal | vauthors = Fleming I | title = The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease | journal = Pharmacological Reviews | volume = 66 | issue = 4 | pages = 1106β40 | date = October 2014 | pmid = 25244930 | doi = 10.1124/pr.113.007781 | doi-access = }}</ref> The CYP3A4 enzyme is also reported to have fatty acid monooxgenase activity for metabolizing arachidonic acid to [[20-Hydroxyeicosatetraenoic acid]] (20-HETE).<ref name="pmid11375247">{{cite journal | vauthors = Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M, Kameo K | title = HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme | journal = British Journal of Pharmacology | volume = 133 | issue = 3 | pages = 325β9 | date = June 2001 | pmid = 11375247 | pmc = 1572803 | doi = 10.1038/sj.bjp.0704101 }}</ref> 20-HETE has a wide range of activities that include growth stimulation in breast and other types of cancers (see [[12-hydroxyeicosatetraenoic acid#cancer|12-hydroxyeicosatetraenoic acid]]).
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)